SCOPUS 정보 검색 플랫폼

Volumn 47, Issue SUPPL. 2, 2001, Pages 127-133

Gastrointestinal cancer refractory to chemotherapy: A role for octreotide?

(6) Cascinu, Stefano a,b Catalano, Vincenzo a Giordani, Paolo a Baldelli, Anna Maria a Agostinelli, Romina a Catalano, Giuseppina a

a SAN SALVATORE HOSPITAL (Italy)

b Maggiore University Hospital (Italy)

Author keywords

Chemotherapy; Gastrointestinal cancers; Octreotide

Indexed keywords

FLUOROURACIL; OCTREOTIDE;

ANTINEOPLASTIC ACTIVITY; CANCER SURVIVAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS, HORMONAL; DRUG RESISTANCE, NEOPLASM; GASTROINTESTINAL NEOPLASMS; HUMANS; OCTREOTIDE; RECEPTORS, SOMATOSTATIN;

EID: 0035086669 PISSN: 00093157 EISSN: None Source Type: Journal
DOI: 10.1159/000049165 Document Type: Review

Times cited : (9)

References (39)

1
- 0005628934
- Philadelphia, Lippincott
- (1992) Gastrointestinal Oncology, ed 3
- Ahlgren, J.D.¹ Mac Donald, J.S.²

2
- 0030000717
- Chemotherapy of gastric cancer
- (1996) Anticancer Drugs , vol.7 , pp. 137-149
- Schipper, D.L.¹ Wagener, D.J.T.²

3
- 0030949430
- Treatment of colorectal cancer
- (1997) Drugs , vol.53 , pp. 593-607
- Labianca, R.¹ Pessi, M.A.² Zamparelli, G.³

4
- 0031809921
- Chemotherapy for advanced pancreatic cancer: The history is changing
- (1998) Tumori , vol.84 , pp. 308-311
- Graziano, F.¹ Catalano, G.² Cascinu, S.³

5
- 0026578468
- Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5fluorouracil/leucovorin combination
- (1992) J Chemother , vol.4 , pp. 46-49
- Cascinu, S.¹ Fedeli, A.² Luzi Fedeli, S.³ Catalano, G.⁴

6
- 0024851311
- Effects of gastrointestinal peptides on gastrointestinal cancer growth
- (1989) Gastroenterol Clin , vol.18 , pp. 777-791
- Townsend, C.M.¹ Singh, P.² Thompson, J.C.³

7
- 0026538194
- Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factors I, II and transforming growth factor α
- (1992) Br J Cancer , vol.65 , pp. 341-346
- Lahm, H.¹ Svardet, L.² Laurent, P.L.³ Fisher, J.R.⁴ Leyhan, A.⁵ Givel, J.C.⁶ Odartchenko, N.⁷

8
- 0026011182
- Co-stimulation of gastrointestinal tumor growth by gastrin, transforming cell growth factor alpha and insulin like growth factors and cancer
- (1991) Br J Cancer , vol.63 , pp. 67-70
- Durrant, L.G.¹ Watson, S.A.² Hall, A.³ Morris, D.L.⁴

9
- 0023192577
- Potential role of somatostatin analogues in the treatment of cancer
- (1987) Eur J Clin Invest , vol.17 , pp. 281-287
- Lamberts, S.W.J.¹

10
- 0018373589
- Metabolic clearance and plasma half disappearance time of exogenous somatostatin in man
- (1979) J Clin Endocrinol Metab , vol.48 , pp. 50-53
- Sheppard, M.C.¹ Shapiro, B.² Pimstone, B.³ Kronhein, S.⁴ Berelowitz, M.⁵ Gregory, M.⁶

11
- 0030054029
- Octreotide
- (1996) N Engl J Med , vol.334 , pp. 246-254
- Lamberts, S.W.J.¹ Van der Lely, A.J.² De Herder, W.W.³ Hofland, L.J.⁴

12
- 0001472624
- Octreotide and nonendocrine tumours: Basic knowledge and therapeutic potential, in Scarpignato C (ed): Octreotide: From Basic Science to Clinical Medicine
- Basel, Karger
- (1996) Prog Basic Clin Pharmacol , vol.10 , pp. 246-269
- Reubi, J.C.¹

13
- 0028929754
- Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtype SSTR2 and SSTR5 through different mechanisms
- (1995) Proc Natl Acad Sci USA , vol.92 , pp. 1580-1584
- Buscail, L.¹ Esteve, J.P.² Saint-Laurent, N.³

14
- 0031025637
- SST2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
- (1997) Cancer Res , vol.57 , pp. 956-962
- Delesque, N.¹ Buscail, L.² Esteve, J.P.³ Saint-Laurent, N.⁴ Muller, C.⁵ Weckbecker, G.⁶ Bruns, C.⁷ Vaysse, N.⁸ Susini, C.⁹

15
- 0026575733
- SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer
- (1992) Cancer Res , vol.52 , pp. 917-923
- Dy, D.Y.¹ Whitehead, R.H.² Morris, D.L.³

16
- 0024443313
- Somatomedin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I
- (1989) Anticancer Res , vol.9 , pp. 889-892
- Pollak, M.N.¹ Polychronakos, C.² Guyda, H.³

17
- 0026547328
- Insulin like growth factor is an autocrine regulator of human colon cancer cell differentiation and growth
- (1992) Cancer Lett , vol.62 , pp. 23-33
- Baghdiguian, S.¹ Verrier, B.² Gerard, C.³ Fantini, J.⁴

18
- 0028890744
- The insulin-like growth factor I receptor: A key to tumor growth?
- (1995) Cancer Res , vol.55 , pp. 249-252
- Baserga, R.¹

19
- 0030756569
- Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients
- (1997) Gastroenterology , vol.113 , pp. 767-772
- Cascinu, S.¹ Del Ferro, E.² Grianti, C.³ Ligi, M.⁴ Ghiselli, M.⁵ Foglietti, G.⁶ Saba, V.⁷ Lungarotti, F.⁸ Catalano, G.⁹

20
- 0031424018
- Lack of correlation between octreotide dose and decrease of serum insulin growth factor I in advanced colorectal cancer patients
- (1997) GI Cancer , vol.2 , pp. 139-142
- Cascinu, S.¹ Del Ferro, E.² Ligi, M.³ Rocchi, M.B.L.⁴ Castellani, A.⁵ Graziano, F.⁶ Ghiandoni, G.⁷ Catalano, G.⁸

21
- 0029090959
- Octreotide reduces the kinetic index, proliferating cell nuclear antigen-maximum proliferative index, in patients with colorectal cancer
- (1995) Cancer , vol.76 , pp. 572-578
- Stewart, G.J.¹ Connor, J.L.² Lawson, J.A.³ Preketes, A.⁴ King, J.⁵ Morris, D.L.⁶

22
- 0025878546
- The effect of long acting somatostatin analogue SMS 201.995 therapy on tumor kinetic measurements and serum tumor marker concentrations in primary rectal cancer
- (1991) Br J Cancer , vol.63 , pp. 971-974
- Iftikhar, S.Y.¹ Watson, S.A.² Morris, D.L.³

23
- 0025086788
- Treatment of patients with metastatic pancreatic and gastrointestinal tumors with the somatostatin analogue Sandostatin: A phase II study including endocrine effects
- (1990) Br J Cancer , vol.62 , pp. 627-630
- Klijn, J.G.M.¹ Hoff, A.M.² Planting, A.S.Th.³ Verweij, J.⁴ Kok, T.⁵ Lamberts, S.W.J.⁶ Portengen, H.⁷ Foekens, J.A.⁸

24
- 0027008734
- Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995
- (1992) Diabète Métab , vol.18 , pp. 438-444
- Mallet, B.¹ Vialettes, B.² Haroche, S.³ Ecoffer, P.⁴ Gastaut, P.⁵ Taubert, J.P.⁶ Vague, P.⁷

25
- 0035088317
- Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients
- in press
- Cancer Invest
- Cascinu, S.¹ Del Ferro, E.² Ligi, M.³ Staccioli, M.P.⁴ Giordani, P.⁵ Catalano, V.⁶ Agostinelli, R.⁷ Muretto, P.⁸ Catalano, G.⁹

26
- 0026500158
- Somatostatin and growth hormone regulation in cancer
- (1992) Biotherapy , vol.4 , pp. 31-36
- Manni, A.¹

27
- 0024213731
- Oncological applications of somatostatin analogues
- (1988) Cancer Res , vol.48 , pp. 6977-6985
- Schally, A.V.¹

28
- 0023325003
- SM 201-995 treatment and advanced intestinal cancer: A pilot study
- (1987) Aliment Pharmacol Ther , vol.1 , pp. 133-139
- Savage, A.P.¹ Calam, J.² Wood, C.B.³ Bloom, S.R.⁴

29
- 0005632707
- Effects of octreotide, a long-acting somatostatin analog, on advanced colon cancer
- (1992) Gastroenterology , vol.102 , pp. 399
- Smith, J.P.¹ Croitorou, R.² Townsend, C.M.³ Thompson, J.C.⁴

30
- 0028105803
- Role of octreotide in the treatment of pancreatic cancer
- (1994) Digestion , vol.55 , pp. 48-51
- Ebert, M.¹ Friess, H.² Beger, H.G.³ Büchler, M.W.⁴

31
- 0027216975
- Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer
- (1993) Pancreas , vol.8 , pp. 540-555
- Friess, H.¹ Büchler, M.W.² Beglinger, C.³ Weber, A.⁴ Kunz, J.⁵ Fritsch, K.⁶ Dennler, H.J.⁷ Beger, H.G.⁸

32
- 0027739818
- Treatment of advanced pancreatic cancer with high-dose octreotide
- (1993) Int J Pancreatol , vol.14 , pp. 290-291
- Friess, H.¹ Büchler, M.W.² Ebert, M.³ Malfertheiner, P.⁴ Dennler, H.J.⁵ Beger, H.G.⁶

33
- 0028859242
- Low-dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas
- (1995) Cancer , vol.75 , pp. 23-28
- Rosenberg, L.¹ Barkun, A.N.² Denis, M.H.³ Pollak, M.⁴

34
- 0029125780
- A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
- (1995) Cancer , vol.76 , pp. 961-966
- Goldberg, R.M.¹ Moertel, C.G.² Wieand, H.J.S.³ Krook, J.E.⁴ Schutt, A.J.⁵ Veeder, M.H.⁶ Maillard, J.A.⁷ Dalton, R.J.⁸

35
- 0005537055
- A phase III evaluation of octreotide versus chemotherapy with 5FU or 5FU/leucovorin in advanced exocrine pancreatic cancer
- (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 488
- Burch, P.A.¹ Block, M.² Wieand, H.S.³ Veeder, M.H.⁴ Michalak, J.C.⁵ Hatfield, A.K.⁶ Wright, K.⁷

36
- 0000048607
- A phase III trial of SMS 201-995 LAR and continuous infusion 5FU in unresectable stage II, III, IV pancreatic cancer
- (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 987
- Roy, A.¹ Jacobs, A.² Bukowsky, R.³ Cunningham, D.⁴ Hamm, J.⁵ Schlag, P.M.⁶ Rosen, P.⁷ Francois, E.⁸ Finley, G.⁹ Lipton, A.¹⁰ Bruckner, H.¹¹ Haller, D.¹² Conroy, T.¹³ Goel, R.¹⁴ Price, P.¹⁵ Smith, G.¹⁶ Mietlowski, W.¹⁷ Linnart, R.¹⁸ Russo, D.¹⁹ Kay, A.²⁰ more..

37
- 0000048604
- Phase III trial of SMS 201-995 LAR vs placebo in unresectable stage II, III, IV pancreatic cancer
- (1998) Proc Am Soc Clin Oncol , vol.17 , pp. 988
- Pederzoli, P.¹ Maurer, U.² Vollmer, K.³ Büchler, M.W.⁴ Kjaeve, J.⁵ Van Cutsem, E.⁶ Di Carlo, V.⁷ Stauder, H.⁸ Bergan, A.⁹ Ebert, M.¹⁰ Kiese, B.¹¹ Raymond, M.C.¹² Kay, A.¹³

38
- 0028878559
- A randomized trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy
- (1995) Br J Cancer , vol.71 , pp. 97-101
- Cascinu, S.¹ Del Ferro, E.² Catalano, G.³

39
- 0027445761
- Octreotide in relieving gastrointestinal symptoms due to bowel obstruction
- (1993) Palliat Med , vol.7 , pp. 295-299
- Mercadante, S.¹ Spoldi, E.² Caraceni, A.³ Maddaloni, S.⁴ Simonetti, M.T.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.